Selective apoptosis of lung cancer cells with talc.

accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002; 41: 1–29. 4 Farris AB 3rd., Mark EJ., Kradin RL, Pulmonary ‘‘inflammatory myofibroblastic’’ tumors: a critical examination of the diagnostic category based on quantitative immunohistochemical analysis. Virchows Arch 2007; 450: 585–590. 5 Chun YS, Wang L, Nascimento AG, et al. Pediatric inflammatory myofibroblastic tumour: anaplastic lymphoma kinase (ALK) expression and prognosis. Pediatr Blood Cancer 2005; 45: 796–801. 6 Fukano R, Matsubara T, Inoue T, et al. Time lag between the increase of IL-6 with fever and NF-kB activation in the peripheral blood in inflammatory myofibroblastic tumour. Cytokine 2008; 44: 293–297. 7 Sato M, Takasaka I, Okumura T, et al. F-18 fluorodeoxyglucose accumulation in an inflammatory pseudotumor of the spleen. Ann Nucl Med 2007; 21: 521–524. 8 Reddy MP, Menda Y, Floresca J, et al. FDG positron emission tomographic imaging of pseudo-pseudo tumor. Clin Nucl Med 2002; 27: 445–446. 9 Reubi JC, Kappeler A, Waser B, et al. Immunohistochemical localization of somatostatin receptors sst2A in human tumors. Am J Pathol 1998; 153: 233–245. 10 Paran D, Paran H. Somatostatin analogs in rheumatoid arthritis and other inflammatory and immune-mediated conditions. Curr Opin Investig Drugs 2003; 4: 578–582.